Infection Clinical Trial
To evaluate granulocyte transfusion therapy with respect to its prophylactic and therapeutic effectiveness to prevent and aid recovery from infection. The study trials were conducted simultaneously.
BACKGROUND:
Infection remains a major cause of death in patients receiving chemotherapy for malignant
diseases. One approach to the problem of septicemia and high mortality in these patients was
the therapeutic use of granulocyte transfusions. Improvements in collection techniques,
employing continuous flow centrifugation, permitted the collection of granulocytes from a
single, normal donor in sufficient numbers to study their application in the treatment of
infections in granulocytopenic patients. Studies had demonstrated the efficacy of
granulocyte transfusions as an adjunct in the therapy of septicemia due to gram negative
microorganisms associated with granulocytopenia.
The aims of the study were to determine (1) whether infections could be prevented in
patients who received granulocytes prophylactically and (2) whether recovery from infection
was aided in patients who received granulocytes therapeutically. Both trials utilized
controls who received no granulocytes.
Four contracts were awarded in September 1976. The protocol designed to evaluate the
efficacy of prophylactic granulocyte transfusions was completed at the close of 1977. The
protocol for the therapeutic trial was completed in April 1978. Approximately 90 patients
were randomized in the prophylactic trial and 51 in the therapeutic trial. The Recruitment
and Intervention Phase ended in February 1980. The trial has concluded.
DESIGN NARRATIVE:
Prophylactic Trial and Therapeutic Trial: randomized, non-blind, sequential. Eligible
patients were randomized to daily granulocyte transfusions or no granulocyte transfusions.
The study completion date listed in this record was inferred from the first publication
listed in the Citations section of this study record.
;
Allocation: Randomized, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |